Anti-reflux Mucosal Valvuloplasty Versus PPIs for GERD Treatment

Recruiting now · Not applicable

Conditions studied: Gastroesophageal Reflux Disease

In brief

The study objective is to evaluate the relative merits, safety and effectiveness of Anti-reflux mucosal valvuloplasty (ARMV) in GERD patients currently treated with daily Proton Pump Inhibitors (PPIs).

Key facts

Study ID
NCT06348420
Run by
Qilu Hospital of Shandong University
People needed
74
Starts
2024-09-10
Expected to finish
2028-12-30
Last updated by the study team
2024-11-18

Who can join

Age: 18 and older, up to 60. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.